June 16, 2025 03:04 PM EDT
Pharma
Marketing

Eli Lil­ly makes all Zep­bound dos­es avail­able in sin­gle-dose vials 

Nicole DeFeudis

Editor

Eli Lil­ly said it will make the two high­est dos­es of its pop­u­lar obe­si­ty drug Zep­bound avail­able to cer­tain pa­tients in cheap­er, sin­gle-dose vials. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

What's com­ing in five years? FDA chief points to uni­ver­sal flu vac­cine, new ap­proval path­way

Ab­b­Vie’s can­cer drug fails Phase 3 com­bo study to treat oth­er bone mar­row dis­eases

Up­dat­ed: Sage's roller coast­er ends in $561M ac­qui­si­tion by Su­per­nus

Roche moves ahead with Phase 3 Parkin­son’s study de­spite mixed tri­al re­sults

NextCure inks ADC deal with Shang­hai drug­mak­er

sponsored

This com­pa­ny has spent a decade in­no­vat­ing NGS-based com­pan­ion di­ag­nos­tics world­wide–what’s next?

A service from the Financial Times